Healthcare provider profile · identity verified

William Martin Rutledge, MD

Family Practice · ORANGE, TX · NPI 1487761375

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	143
Levothyroxine Sodium	Levothyroxine Sodium	479	130
Amlodipine Besylate	Amlodipine Besylate	439	119
Rosuvastatin Calcium	Rosuvastatin Calcium	376	110
Azithromycin	Azithromycin	284	214
Lisinopril	Lisinopril	281	79
Losartan Potassium	Losartan Potassium	234	70
Pravastatin Sodium	Pravastatin Sodium	222	66
Montelukast Sodium	Montelukast Sodium	219	73
Metformin Hcl	Metformin Hcl	215	64
Omeprazole	Omeprazole	195	54
Pantoprazole Sodium	Pantoprazole Sodium	192	58
Simvastatin	Simvastatin	190	48
Metoprolol Succinate	Metoprolol Succinate	173	51
Escitalopram Oxalate	Escitalopram Oxalate	169	51
Gabapentin	Gabapentin	167	64
Hydrochlorothiazide	Hydrochlorothiazide	164	51
Cephalexin	Cephalexin	159	109
Carvedilol	Carvedilol	155	44
Tamsulosin Hcl	Tamsulosin Hcl	153	45
Allopurinol	Allopurinol	152	42
Ezetimibe	Ezetimibe	137	40
Alprazolam	Alprazolam	130	43
Famotidine	Famotidine	130	38
Clopidogrel	Clopidogrel Bisulfate	123	37
Furosemide	Furosemide	116	37
Meloxicam	Meloxicam	116	29
Trazodone Hcl	Trazodone Hcl	106	27
Eliquis	Apixaban	105	24
Pioglitazone Hcl	Pioglitazone Hcl	105	25
Sertraline Hcl	Sertraline Hcl	105	30
Ramipril	Ramipril	92	23
Albuterol Sulfate Hfa	Albuterol Sulfate	85	39
Tizanidine Hcl	Tizanidine Hcl	83	32
Methylprednisolone	Methylprednisolone	81	79
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	79	59
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	19
Buspirone Hcl	Buspirone Hcl	61	15
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	57	41
Metformin Hcl Er	Metformin Hcl	57	15
Azelastine Hcl	Azelastine Hcl	54	35
Celecoxib	Celecoxib	53	24
Metoprolol Tartrate	Metoprolol Tartrate	53	18
Doxycycline Hyclate	Doxycycline Hyclate	51	40
Lorazepam	Lorazepam	51	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	51	15
Estradiol	Estradiol	50	14
Hydroxyzine Hcl	Hydroxyzine Hcl	50	14
Citalopram Hbr	Citalopram Hydrobromide	48	13
Synthroid	Levothyroxine Sodium	48	14
Tramadol Hcl	Tramadol Hcl	48	24
Atenolol	Atenolol	46	13
Paroxetine Hcl	Paroxetine Hcl	46	11
Potassium Chloride	Potassium Chloride	44	16
Zolpidem Tartrate	Zolpidem Tartrate	44	13
Bisoprolol Fumarate	Bisoprolol Fumarate	42	12
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Fluconazole	Fluconazole	40	21
Glimepiride	Glimepiride	40	12
Niacin Er	Niacin	40	12
Clonazepam	Clonazepam	39	suppressed
Ondansetron Odt	Ondansetron	37	27
Bupropion Xl	Bupropion Hcl	36	suppressed
Diazepam	Diazepam	35	suppressed
Enalapril Maleate	Enalapril Maleate	35	suppressed
Finasteride	Finasteride	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Clonidine Hcl	Clonidine Hcl	31	13
Prednisone	Prednisone	31	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Acyclovir	Acyclovir	29	15
Lovastatin	Lovastatin	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	29	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Temazepam	Temazepam	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	11
Irbesartan	Irbesartan	24	suppressed
Valsartan	Valsartan	24	suppressed
Nystatin	Nystatin	23	15
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Topiramate	Topiramate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Ozempic	Semaglutide	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Amoxicillin	Amoxicillin	18	13
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Meclizine Hcl	Meclizine Hcl	17	11
Mometasone Furoate	Mometasone Furoate	17	12
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Colchicine	Colchicine	15	11
Ketoconazole	Ketoconazole	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Carvedilol Er	Carvedilol Phosphate	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Nexletol	Bempedoic Acid	13	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	13	13
Xarelto	Rivaroxaban	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error